UnitedHealth Group (NYSE:UNH) Stock Price Expected to Rise, Bank of America Analyst Says

Posted by George Bondi on Jun 24th, 2026

UnitedHealth Group (NYSE:UNH – Get Free Report) had its target price increased by investment analysts at Bank of America from $450.00 to $475.00 in a research note issued on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the healthcare conglomerate’s stock. Bank of America‘s target price suggests a potential upside of 17.52% from the stock’s current price.

UNH has been the subject of several other research reports. Truist Financial boosted their price objective on UnitedHealth Group from $395.00 to $440.00 and gave the company a “buy” rating in a report on Monday, June 1st. Leerink Partners boosted their price target on UnitedHealth Group from $400.00 to $462.00 and gave the company an “outperform” rating in a report on Wednesday, June 17th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, June 11th. Sanford C. Bernstein reissued an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday. Finally, Barclays upped their price objective on shares of UnitedHealth Group from $373.00 to $429.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 26th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $410.79.

Get Our Latest Research Report on UNH

UnitedHealth Group Stock Performance

NYSE UNH traded down $5.05 on Wednesday, hitting $404.20. 2,643,996 shares of the company’s stock traded hands, compared to its average volume of 8,753,969. The firm has a market capitalization of $367.07 billion, a PE ratio of 30.54, a P/E/G ratio of 1.64 and a beta of 0.64. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $415.98. The firm’s 50-day moving average price is $377.77 and its two-hundred day moving average price is $330.66. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.76 by $0.47. The firm had revenue of $111.65 billion during the quarter, compared to analysts’ expectations of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The firm’s revenue was up 2.0% compared to the same quarter last year. During the same quarter last year, the company posted $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, analysts expect that UnitedHealth Group will post 18.32 EPS for the current year.

Insiders Place Their Bets

In related news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the sale, the chief executive officer directly owned 17,805 shares in the company, valued at approximately $6,320,775. The trade was a 4.30% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.28% of the company’s stock.

Institutional Trading of UnitedHealth Group

Large investors have recently made changes to their positions in the company. Redwood Investment Management LLC acquired a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $764,000. Sapient Capital LLC increased its stake in shares of UnitedHealth Group by 24.8% in the 1st quarter. Sapient Capital LLC now owns 3,091 shares of the healthcare conglomerate’s stock worth $836,000 after acquiring an additional 615 shares during the last quarter. Vilga Financial Planning LLC boosted its position in shares of UnitedHealth Group by 4.9% during the 1st quarter. Vilga Financial Planning LLC now owns 764 shares of the healthcare conglomerate’s stock valued at $207,000 after acquiring an additional 36 shares during the last quarter. FAS Wealth Partners Inc. increased its position in UnitedHealth Group by 270.7% during the first quarter. FAS Wealth Partners Inc. now owns 11,283 shares of the healthcare conglomerate’s stock worth $3,053,000 after purchasing an additional 8,239 shares during the last quarter. Finally, Farmers National Bank boosted its holdings in UnitedHealth Group by 1.6% in the 1st quarter. Farmers National Bank now owns 9,261 shares of the healthcare conglomerate’s stock valued at $2,506,000 after purchasing an additional 149 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

(Get Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.